Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, and more. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results. Originally published by Bentham and now distributed by Elsevier, Anti-Angiogenesis Drug Discovery and Development, Volume 2 is an compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews ha

Neovascularization inhibitors. --- Angiogenesis inhibitors --- Tumor angiogenesis inhibitors --- Antineoplastic agents

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Frontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest and the most important advances in anti-cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. Each: Volume is devoted to the major advances in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.The eighth: Volume of the series features chapters covering the following topics:- T cells in gastrointestinal cancers- The pharmacology of adjudin - a male contraceptive with anti-cancer properties- Manipulating the tumor microenvironment- Treatment of hepatocellular carcinoma- Gold-based compounds as potential anti-cancer drug candidates- Oral nanostructure drug delivery for anti-cancer treatment

Antineoplastic agents. --- Anticancer agents --- Antineoplastic drugs --- Antineoplastics --- Antitumor agents --- Antitumor drugs --- Cytotoxic drugs --- Inhibitors, Neoplasm --- Neoplasm inhibitors --- Drugs --- Cancer --- Chemotherapy

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Applications of NMR Spectroscopy is a book series devoted to publishing the latest advances in the applications of nuclear magnetic resonance (NMR) spectroscopy in various fields of organic chemistry, biochemistry, health and agriculture. The ninth volume of the series features reviews that highlight NMR spectroscopic techniques in microbiology, food science, pharmaceutical analysis and cancer diagnosis. The reviews in this volume are: - NMR spectroscopy for the characterization of photoprotective compounds in cyanobacteria - Coffee assessment using 1H NMR spectroscopy and multivariate data analysis: a review - Evaluation of structure-property relationship of coconut shell lignins by NMR spectroscopy: from biorefinery to high-added value products - Application of NMR spectroscopy in chiral recognition of drugs - NMR-based metabolomics: general aspects and applications in cancer diagnosis.

Nuclear magnetic resonance spectroscopy.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Drug Design and Discovery in Alzheimer's Disease includes expert reviews of recent developments in Alzheimer's disease (AD) and neurodegenerative disease research. Originally published by Bentham as Frontiers in Drug Design and Discovery, Volume 6and now distributed by Elsevier, this compilation of the sixteen articles, written by leading global researchers, focuses on key developments in the understanding of the disease at molecular levels, identification and validation of molecular targets, as well as innovative approaches towards drug discovery, development, and delivery. Beginning with an.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Neovascularization inhibitors.